查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1944396

全球胸廓出口症候群市場：按給藥途徑、技術/作用機制、藥物類別、產品類型、適應症、最終用戶、國家和地區分類－產業分析、市場規模、佔有率和預測（2025-2032）

Thoracic Outlet Syndrome Market, By Route of Administration, By Technology/Mode of Action, By Drug Class, By Product Type, By Application, By End-User, By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 389 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2024 年胸廓出口症候群 (TOS) 市場規模價值為 2.2119 億美元，從 2025 年到 2032 年將以 5.50% 的複合年成長率成長。

胸廓出口症候群 (TOS) 市場涵蓋診斷服務、治療性介入以及用於治療頸肩部神經、靜脈和動脈受壓的手術方案。重複性勞損和與久坐生活方式及體力勞動強度大的職業相關的姿勢相關疾病的增加，正在推動市場成長。一個顯著的趨勢是，在先進影像和神經監測技術的支持下，微創減壓手術正逐漸興起。然而，人們對 TOS 的認知度低以及誤診率高仍然是主要障礙。儘管存在這些挑戰，但擴大復健計劃、實施符合人體工學的解決方案以及加強臨床醫生培訓，為改善早期診斷、提高治療效果和促進市場整體擴張提供了重要機會。

胸廓出口症候群市場動態

藥物療法的日益普及將推動市場成長

由於越來越多的患者選擇藥物治療作為手術介入前的首選治療方案，胸廓出口症候群市場正在成長。醫生擴大使用抗發炎藥物、肌肉鬆弛劑和止痛藥等藥物來緩解症狀並改善患者預後，尤其是在神經源性胸廓出口症候群的病例中。這種保守治療方法減少了侵入性手術的需求，縮短了恢復時間，並有助於提高患者的長期依從性。正在進行的臨床研究進一步強化了這一趨勢，這些研究比較了保守治療和手術治療的效果，並證實了非手術治療方案的有效性。例如，馬斯垂克大學2022年7月的一項研究比較了神經源性胸廓出口症候群患者的手術治療和持續保守治療，結果顯示，50名患者最初接受了保守治療，這反映了藥物治療的日益普及。

胸廓出口症候群市場：細分分析

全球胸廓出口症候群市場按給藥途徑、技術/作用機制、藥物類別/產品類型、適應症、最終用戶和地區進行細分。

口服給藥途徑佔主導地位。截至2024年，口服給藥途徑佔總給藥途徑的絕大部分。隨著胸廓出口症候群（TOS）病例的增加，尤其是神經源性TOS病例的增加，由於口服藥物的便利性和可及性，其使用量也不斷增加。因此，口服藥物已成為熱門選擇，促進了該領域的成長。根據梅奧診所2023年發布的《胸廓出口症候群治療指南》，非類固醇消炎劑（NSAIDs），如Ibuprofen和萘普生，是常用的口服處方藥，可減輕患者的發炎和疼痛。

神經源性胸廓出口症候群（TOS）細分市場仍然是最大的市場佔有率貢獻者，這主要得益於其高發病率和不斷成長的病例數。神經源性TOS是該疾病最常見的類型，因此對診斷服務和治療性介入的需求不斷增加。根據美國國家醫學圖書館（2022年10月）的數據，神經源性TOS的年發生率估計為每10萬人2-3例，盛行率約為每10萬人10例。此亞型約佔所有TOS病例的90-95%，凸顯了其在塑造市場動態的主導地位。

胸廓出口症候群市場—區域分析

北美憑藉其高度發展的診斷中心體系、現代影像診斷技術的積極應用以及眾多多專科中心，佔據了顯著的市場佔有率。醫生、物理治療師和外科醫生臨床意識的提高，使得神經性、靜脈性和動脈性胸廓出口症候群（TOS）的早期發現和鑑別成為可能。微創手術技術、全面的復健計畫以及完善的健保報銷體系，共同確保了病患獲得必要的治療。此外，美國和加拿大的領導企業醫療設備市場和研究機構持續投資於先進的手術器材、電腦診斷和姿勢測試技術，進一步鞏固了北美在全球市場的主導地位。

美國胸廓出口症候群市場—國家分析

美國預計將引領北美胸廓出口症候群市場，這主要得益於運動員中該症候群發病率的不斷上升，以及美國先進的醫療基礎設施普及，從而能夠及時診斷和有效治療。強大的臨床能力和專業的醫療中心進一步鞏固了美國的市場地位。例如，根據美國國立衛生研究院（NIH）2024年10月發布的數據，一項研究旨在確定2010年至2021年美國胸廓出口症候群的住院負擔和治療結果。結果顯示，37,174例住院病例中，靜脈型胸廓出口症候群佔7,397例，動脈型胸廓出口症候群佔3,346例，神經型胸廓出口症候群佔26,430例。

目錄

第1章 胸廓出口症候群市場概覽

  • 分析範圍
  • 市場估算期

第2章執行摘要

  • 市場區隔
  • 競爭考察

第3章 胸廓出口症候群的主要市場趨勢

  • 市場促進因素
  • 市場限制
  • 市場機遇
  • 未來市場趨勢

4. 胸廓出口症候群市場：產業分析

  • PEST分析
  • 波特五力分析
  • 市場成長展望：概覽
  • 管理體制分析

第5章 胸廓出口症候群市場：地緣政治緊張局勢加劇的影響

  • 新冠疫情的影響
  • 俄烏戰爭的影響
  • 中東衝突的影響

第6章 胸廓出口症候群市場現狀

  • 胸廓出口症候群市場佔有率分析（2024 年）
  • 主要製造商的細分數據
    • 對現有公司的分析
    • 新興企業分析

7. 胸廓出口症候群市場（依給藥途徑分類）

  • 概述
    • 細分市場佔有率分析：依管理途徑
    • 腸外
    • 口服
    • 其他

8. 依技術/作用機轉分類的胸廓出口症候群市場

  • 概述
    • 細分市場佔有率分析：依技術/作用機制分類
    • 神經和血管減壓裝置
    • 物理復健與手法治療技術
    • 微創手術技術
    • 藥物鎮痛
    • 影像和診斷方法

9. 胸廓出口症候群藥物市場

  • 概述
    • 細分市場佔有率分析：依藥物類別分類
    • 非類固醇消炎劑（NSAIDs）
    • 抗凝血劑
    • 皮質類固醇
    • 肌肉鬆弛劑
    • 溶栓藥物
    • 其他

第10章 胸廓出口症候群市場（依產品類型分類）

  • 概述
    • 細分市場佔有率分析：依產品類型
    • 物理治療和復健解決方案
      • 神經滑動法
      • 姿勢矯正計劃
    • 藥物治療
      • 非類固醇消炎劑（NSAIDs）
      • 神經病變疼痛藥物
      • 肌肉鬆弛劑
    • 影像診斷和評估工具
      • 多普勒超音波系統
      • MRI/CT影像診斷系統
    • 外科手術器械及設備
      • 第一肋骨切除器械
      • 斜角肌切除器械
    • 輔助/輔助處理設備
      • 疼痛管理裝置
      • 矯正器具

第11章 胸廓出口症候群市場（依應用領域分類）

  • 概述
    • 細分市場佔有率分析：按應用
    • 動脈胸廓出口症候群
    • 靜脈性胸廓出口症候群
    • 神經源性胸廓出口症候群
    • 混合型/特異性胸廓出口症候群

第12章 胸廓出口症候群市場（依最終用戶分類）

  • 概述
    • 細分市場佔有率分析：依最終用戶分類
    • 醫院及專科醫療中心
    • 物理治療和復健診所
    • 門診手術中心
    • 診斷影像中心
    • 其他最終用戶

第13章 胸廓出口症候群市場：依地區分類

  • 介紹
  • 北美洲
    • 概述
    • 北美主要製造商
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲主要製造商
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 瑞典
    • 俄羅斯
    • 波蘭
    • 其他
  • 亞太地區
    • 概述
    • 亞太地區主要製造商
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 菲律賓
    • 其他
  • 拉丁美洲
    • 概述
    • 拉丁美洲主要製造商
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 其他
  • 中東和非洲
    • 概述
    • 中東和非洲的主要製造商
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • 其他

第14章 主要供應商分析：胸廓出口症候群產業

  • 競爭對手儀錶板
    • 競爭基準
    • 競爭定位
  • 公司簡介
    • Stryker
    • Globus Medical
    • Becton Dickinson（BD）
    • Smith and Nephew
    • Hologi
    • Zimmer Biomet
    • Cook Medical
    • Abbott
    • B. Braun
    • Teleflex
    • Philips Healthcare
    • Terumo Corporation
    • Medtronic
    • Cardinal Health
    • Boston Scientific
    • CONMED Corporation
    • Johnson &Johnson（DePuy Synthes）
    • Siemens Healthineers
    • GE HealthCare
    • Koninklijke Philips
    • NuVasive
    • Arthrex
    • AngioDynamics
    • Others

第15章 AnalystView 360度分析

簡介目錄
Product Code: ANV6021

Thoracic Outlet Syndrome Market size was valued at US$ 221.19 Million in 2024, expanding at a CAGR of 5.50% from 2025 to 2032.

The thoracic outlet syndrome (TOS) market includes diagnostic services, therapeutic interventions, and surgical solutions for treating nerve, vein, or artery compression in the neck and shoulder region. The increasing prevalence of repetitive strain injuries and posture-related disorders associated with sedentary lifestyles and physically demanding occupations is driving market growth. A notable trend is the shift toward minimally invasive decompression procedures, which are aided by advanced imaging and nerve monitoring technologies. However, limited awareness and frequent misdiagnosis of TOS are major barriers. Despite this, expanding rehabilitation programs, implementing ergonomic solutions, and improving clinician training offer significant opportunities to improve early diagnosis, treatment outcomes, and overall market expansion.

Thoracic Outlet Syndrome Market- Market Dynamics

Increasing Adoption of Pharmacologic Management Fuel Market Growth

The thoracic outlet syndrome market is witnessing growth due to the increasing use of pharmacologic management as a primary step before surgical intervention. Physicians are increasingly adopting medications such as anti-inflammatory agents, muscle relaxants, and pain management drugs to relieve symptoms and improve patient outcomes, especially in neurogenic TOS cases. This conservative approach helps reduce the need for invasive procedures, shortens recovery time, and supports better long-term patient compliance. The trend is further strengthened by ongoing clinical studies comparing conservative care with surgery, reinforcing the effectiveness of non-surgical treatment pathways. For instance, a July 2022 study by Maastricht University compared surgery versus continued conservative treatment in neurogenic TOS, where 50 patients initially received conservative therapy, reflecting growing adoption of pharmacologic management.

Thoracic Outlet Syndrome Market- Segmentation Analysis:

The Global Thoracic Outlet Syndrome Market is segmented on the basis of Route of Administration, Technology/Mode of Action, Drug Class, Product Type, Application, End-User, and Region.

The oral segment is in dominant position. In 2024, the oral route of administration accounted for majority of the total. The rising number of cases associated with TOS, particularly neurogenic TOS, is driving an increase in the use of oral drugs due to their convenience and availability. As a result, it became a popular choice and contributed to the segment's growth. According to the Mayo Clinic's 2023 treatment guidelines for Thoracic outlet syndrome, NSAIDs such as ibuprofen or naproxen are commonly prescribed oral medications that help to reduce inflammation and pain in patients.

The neurogenic thoracic outlet syndrome (TOS) segment remains the largest market contributor, driven by its high prevalence and rising case numbers. Neurogenic TOS is the most common form of the condition, resulting in increased demand for diagnostic services and therapeutic interventions. As per data from the National Library of Medicine (October 2022), the annual incidence of neurogenic TOS is estimated at 2-3 cases per 100,000 individuals, with a prevalence of around 10 cases per 100,000 population. This subtype represents approximately 90-95% of all TOS cases, underscoring its dominant role in shaping market dynamics.

Thoracic Outlet Syndrome Market- Geographical Insights

North America holds the significant share in the market, owing to its well-developed diagnostic center system, high use of modern imaging methods, and presence of multidisciplinary specialty centers. Clinical awareness among physicians, physiotherapists, and surgeons has resulted in earlier recognition and differentiation of neurogenic, venous, and arterial TOS. Minimally invasive surgical technologies, extensive rehabilitation programs, and well-developed reimbursement schemes all help patients get the treatment they need. Furthermore, the leaders of the medical device market and research facilities in the United States and Canada are constantly investing in better surgical instruments, computerized diagnostics, and postural examinations, confirming North America's global market dominance.

United States Thoracic Outlet Syndrome Market- Country Insights

The United States is projected to lead the North American thoracic outlet syndrome market, supported by the growing incidence of the condition among athletes and broad access to advanced healthcare infrastructure that enables timely diagnosis and effective treatment. Strong clinical capabilities and specialized care centers further reinforce the country's market position. For example, according to NIH data published in October 2024, a study was conducted to determine the burden of in-hospital admissions and outcomes of thoracic outlet compression syndrome in the United States between 2010 and 2021. It was discovered that of the 37,174 hospitalizations, 7,397 were for venous TOS, 3,346 for arterial TOS, and 26,430 for neurogenic TOS.

Thoracic Outlet Syndrome Market- Competitive Landscape:

The thoracic outlet syndrome (TOS) market is moderately competitive, with medical device manufacturers, surgical solution providers, and specialty healthcare service companies focusing on vascular, neurological, and orthopedic care. Advances in minimally invasive surgical techniques, diagnostic imaging, and postoperative rehabilitation solutions are driving competition. To strengthen their market presence, leading players focus on product innovation, clinical training, and strategic partnerships with hospitals and specialty clinics. Companies are also investing in ergonomic and nerve-monitoring technologies to improve surgical outcomes and lower complications. Medtronic, Stryker, Johnson & Johnson (Ethicon), Abbott and Smith+Nephew are key market players that provide surgical instruments, vascular solutions, and supportive technologies for TOS management.

Recent Developments:

In July 2025, Bristol-Myers Squibb Company and Pfizer Inc. announced a new direct-to-patient option for purchasing Eliquis (apixaban) through Eliquis 360 Support.

In August, 2024, Pfizer Inc. announced that the US Department of Health and Human Services has disclosed the "maximum fair price" (MFP) for ELIQUIS (apixaban).

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL THORACIC OUTLET SYNDROME MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Stryker
  • Globus Medical
  • Becton Dickinson (BD)
  • Smith and Nephew
  • Hologi
  • Zimmer Biomet
  • Cook Medical
  • Abbott
  • B. Braun
  • Teleflex
  • Philips Healthcare
  • Terumo Corporation
  • Medtronic
  • Cardinal Health
  • Boston Scientific
  • CONMED Corporation
  • Johnson & Johnson (DePuy Synthes)
  • Siemens Healthineers
  • GE HealthCare
  • Koninklijke Philips
  • NuVasive
  • Arthrex
  • AngioDynamics
  • Others

GLOBAL THORACIC OUTLET SYNDROME MARKET, BY ROUTE OF ADMINISTRATION- MARKET ANALYSIS, 2019 - 2032

  • Parenteral
  • Oral
  • Others

GLOBAL THORACIC OUTLET SYNDROME MARKET, BY TECHNOLOGY/MODE OF ACTION- MARKET ANALYSIS, 2019 - 2032

  • Nerve & Vascular Decompression Tools
  • Physical Rehabilitation & Manual Therapy Techniques
  • Minimally Invasive Surgical Technologies
  • Pharmacological Pain Management
  • Imaging & Diagnostic Modalities

GLOBAL THORACIC OUTLET SYNDROME MARKET, BY DRUG CLASS- MARKET ANALYSIS, 2019 - 2032

  • Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
  • Anticoagulants
  • Corticosteroids
  • Muscle Relaxants
  • Thrombolytics
  • Others

GLOBAL THORACIC OUTLET SYNDROME MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Physical Therapy & Rehabilitation Solutions
  • Nerve-gliding techniques
  • Postural correction programs
  • Pharmacological Treatments
  • NSAIDs
  • Neuropathic pain medications
  • Muscle relaxants
  • Diagnostic Imaging & Evaluation Tools
  • Doppler ultrasound systems
  • MRI/CT imaging systems
  • Surgical Intervention Tools & Devices
  • First rib resection tools
  • Scalenectomy instruments
  • Supportive & Adjunctive Treatment Devices
  • Pain management devices
  • Orthotic braces

GLOBAL THORACIC OUTLET SYNDROME MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Arterial Thoracic Outlet Syndrome
  • Venous Thoracic Outlet Syndrome
  • Neurogenic Thoracic Outlet Syndrome
  • Mixed/Non-specified TOS Conditions

GLOBAL THORACIC OUTLET SYNDROME MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals & Specialty Care Centers
  • Physiotherapy & Rehabilitation Clinics
  • Outpatient Surgical Centers
  • Diagnostic Imaging Centers
  • Other End-Users

GLOBAL THORACIC OUTLET SYNDROME MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Thoracic Outlet Syndrome Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Thoracic Outlet Syndrome Market Snippet by Route of Administration
    • 2.1.2. Thoracic Outlet Syndrome Market Snippet by Technology/Mode of Action
    • 2.1.3. Thoracic Outlet Syndrome Market Snippet by Drug Class
    • 2.1.4. Thoracic Outlet Syndrome Market Snippet by Product Type
    • 2.1.5. Thoracic Outlet Syndrome Market Snippet by Application
    • 2.1.6. Thoracic Outlet Syndrome Market Snippet by End-User
    • 2.1.7. Thoracic Outlet Syndrome Market Snippet by Country
    • 2.1.8. Thoracic Outlet Syndrome Market Snippet by Region
  • 2.2. Competitive Insights

3. Thoracic Outlet Syndrome Key Market Trends

  • 3.1. Thoracic Outlet Syndrome Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Thoracic Outlet Syndrome Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Thoracic Outlet Syndrome Market Opportunities
  • 3.4. Thoracic Outlet Syndrome Market Future Trends

4. Thoracic Outlet Syndrome Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Thoracic Outlet Syndrome Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Thoracic Outlet Syndrome Market Landscape

  • 6.1. Thoracic Outlet Syndrome Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Thoracic Outlet Syndrome Market - By Route of Administration

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Route of Administration, 2024 & 2032 (%)
    • 7.1.2. Parenteral
    • 7.1.3. Oral
    • 7.1.4. Others

8. Thoracic Outlet Syndrome Market - By Technology/Mode of Action

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Technology/Mode of Action, 2024 & 2032 (%)
    • 8.1.2. Nerve & Vascular Decompression Tools
    • 8.1.3. Physical Rehabilitation & Manual Therapy Techniques
    • 8.1.4. Minimally Invasive Surgical Technologies
    • 8.1.5. Pharmacological Pain Management
    • 8.1.6. Imaging & Diagnostic Modalities

9. Thoracic Outlet Syndrome Market - By Drug Class

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Drug Class, 2024 & 2032 (%)
    • 9.1.2. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
    • 9.1.3. Anticoagulants
    • 9.1.4. Corticosteroids
    • 9.1.5. Muscle Relaxants
    • 9.1.6. Thrombolytics
    • 9.1.7. Others

10. Thoracic Outlet Syndrome Market - By Product Type

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Product Type, 2024 & 2032 (%)
    • 10.1.2. Physical Therapy & Rehabilitation Solutions
      • 10.1.2.1. Nerve-gliding techniques
      • 10.1.2.2. Postural correction programs
    • 10.1.3. Pharmacological Treatments
      • 10.1.3.1. NSAIDs
      • 10.1.3.2. Neuropathic pain medications
      • 10.1.3.3. Muscle relaxants
    • 10.1.4. Diagnostic Imaging & Evaluation Tools
      • 10.1.4.1. Doppler ultrasound systems
      • 10.1.4.2. MRI/CT imaging systems
    • 10.1.5. Surgical Intervention Tools & Devices
      • 10.1.5.1. First rib resection tools
      • 10.1.5.2. Scalenectomy instruments
    • 10.1.6. Supportive & Adjunctive Treatment Devices
      • 10.1.6.1. Pain management devices
      • 10.1.6.2. Orthotic braces

11. Thoracic Outlet Syndrome Market - By Application

  • 11.1. Overview
    • 11.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 11.1.2. Arterial Thoracic Outlet Syndrome
    • 11.1.3. Venous Thoracic Outlet Syndrome
    • 11.1.4. Neurogenic Thoracic Outlet Syndrome
    • 11.1.5. Mixed/Non-specified TOS Conditions

12. Thoracic Outlet Syndrome Market - By End-User

  • 12.1. Overview
    • 12.1.1. Segment Share Analysis, By End-User, 2024 & 2032 (%)
    • 12.1.2. Hospitals & Specialty Care Centers
    • 12.1.3. Physiotherapy & Rehabilitation Clinics
    • 12.1.4. Outpatient Surgical Centers
    • 12.1.5. Diagnostic Imaging Centers
    • 12.1.6. Other End-Users

13. Thoracic Outlet Syndrome Market- By Geography

  • 13.1. Introduction
    • 13.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 13.2. North America
    • 13.2.1. Overview
    • 13.2.2. Thoracic Outlet Syndrome Key Manufacturers in North America
    • 13.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 13.2.4. North America Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 13.2.5. North America Market Size and Forecast, By Technology/Mode of Action, 2019 - 2032 (US$ Million)
    • 13.2.6. North America Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
    • 13.2.7. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 13.2.8. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 13.2.9. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 13.2.10. U.S.
      • 13.2.10.1. Overview
      • 13.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.2.10.3. U.S. Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 13.2.10.4. U.S. Market Size and Forecast, By Technology/Mode of Action, 2019 - 2032 (US$ Million)
      • 13.2.10.5. U.S. Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 13.2.10.6. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 13.2.10.7. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.2.10.8. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 13.2.11. Canada
      • 13.2.11.1. Overview
      • 13.2.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.2.11.3. Canada Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 13.2.11.4. Canada Market Size and Forecast, By Technology/Mode of Action, 2019 - 2032 (US$ Million)
      • 13.2.11.5. Canada Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 13.2.11.6. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 13.2.11.7. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.2.11.8. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 13.3. Europe
    • 13.3.1. Overview
    • 13.3.2. Thoracic Outlet Syndrome Key Manufacturers in Europe
    • 13.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 13.3.4. Europe Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 13.3.5. Europe Market Size and Forecast, By Technology/Mode of Action, 2019 - 2032 (US$ Million)
    • 13.3.6. Europe Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
    • 13.3.7. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 13.3.8. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 13.3.9. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 13.3.10. Germany
      • 13.3.10.1. Overview
      • 13.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.3.10.3. Germany Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 13.3.10.4. Germany Market Size and Forecast, By Technology/Mode of Action, 2019 - 2032 (US$ Million)
      • 13.3.10.5. Germany Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 13.3.10.6. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 13.3.10.7. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.3.10.8. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 13.3.11. UK
      • 13.3.11.1. Overview
      • 13.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.3.11.3. UK Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 13.3.11.4. UK Market Size and Forecast, By Technology/Mode of Action, 2019 - 2032 (US$ Million)
      • 13.3.11.5. UK Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 13.3.11.6. UK Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 13.3.11.7. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.3.11.8. UK Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 13.3.12. France
      • 13.3.12.1. Overview
      • 13.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.3.12.3. France Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 13.3.12.4. France Market Size and Forecast, By Technology/Mode of Action, 2019 - 2032 (US$ Million)
      • 13.3.12.5. France Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 13.3.12.6. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 13.3.12.7. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.3.12.8. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 13.3.13. Italy
      • 13.3.13.1. Overview
      • 13.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.3.13.3. Italy Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 13.3.13.4. Italy Market Size and Forecast, By Technology/Mode of Action, 2019 - 2032 (US$ Million)
      • 13.3.13.5. Italy Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 13.3.13.6. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 13.3.13.7. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.3.13.8. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 13.3.14. Spain
      • 13.3.14.1. Overview
      • 13.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.3.14.3. Spain Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 13.3.14.4. Spain Market Size and Forecast, By Technology/Mode of Action, 2019 - 2032 (US$ Million)
      • 13.3.14.5. Spain Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 13.3.14.6. Spain Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 13.3.14.7. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.3.14.8. Spain Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 13.3.15. The Netherlands
      • 13.3.15.1. Overview
      • 13.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.3.15.3. The Netherlands Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 13.3.15.4. The Netherlands Market Size and Forecast, By Technology/Mode of Action, 2019 - 2032 (US$ Million)
      • 13.3.15.5. The Netherlands Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 13.3.15.6. The Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 13.3.15.7. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.3.15.8. The Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 13.3.16. Sweden
      • 13.3.16.1. Overview
      • 13.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.3.16.3. Sweden Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 13.3.16.4. Sweden Market Size and Forecast, By Technology/Mode of Action, 2019 - 2032 (US$ Million)
      • 13.3.16.5. Sweden Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 13.3.16.6. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 13.3.16.7. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.3.16.8. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 13.3.17. Russia
      • 13.3.17.1. Overview
      • 13.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.3.17.3. Russia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 13.3.17.4. Russia Market Size and Forecast, By Technology/Mode of Action, 2019 - 2032 (US$ Million)
      • 13.3.17.5. Russia Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 13.3.17.6. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 13.3.17.7. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.3.17.8. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 13.3.18. Poland
      • 13.3.18.1. Overview
      • 13.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.3.18.3. Poland Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 13.3.18.4. Poland Market Size and Forecast, By Technology/Mode of Action, 2019 - 2032 (US$ Million)
      • 13.3.18.5. Poland Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 13.3.18.6. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 13.3.18.7. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.3.18.8. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 13.3.19. Rest of Europe
      • 13.3.19.1. Overview
      • 13.3.19.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.3.19.3. Rest of the Europe Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 13.3.19.4. Rest of the Europe Market Size and Forecast, By Technology/Mode of Action, 2019 - 2032 (US$ Million)
      • 13.3.19.5. Rest of the Europe Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 13.3.19.6. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 13.3.19.7. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.3.19.8. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 13.4. Asia Pacific (APAC)
    • 13.4.1. Overview
    • 13.4.2. Thoracic Outlet Syndrome Key Manufacturers in Asia Pacific
    • 13.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 13.4.4. APAC Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 13.4.5. APAC Market Size and Forecast, By Technology/Mode of Action, 2019 - 2032 (US$ Million)
    • 13.4.6. APAC Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
    • 13.4.7. APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 13.4.8. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 13.4.9. APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 13.4.10. China
      • 13.4.10.1. Overview
      • 13.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.4.10.3. China Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 13.4.10.4. China Market Size and Forecast, By Technology/Mode of Action, 2019 - 2032 (US$ Million)
      • 13.4.10.5. China Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 13.4.10.6. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 13.4.10.7. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.4.10.8. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 13.4.11. India
      • 13.4.11.1. Overview
      • 13.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.4.11.3. India Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 13.4.11.4. India Market Size and Forecast, By Technology/Mode of Action, 2019 - 2032 (US$ Million)
      • 13.4.11.5. India Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 13.4.11.6. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 13.4.11.7. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.4.11.8. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 13.4.12. Japan
      • 13.4.12.1. Overview
      • 13.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.4.12.3. Japan Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 13.4.12.4. Japan Market Size and Forecast, By Technology/Mode of Action, 2019 - 2032 (US$ Million)
      • 13.4.12.5. Japan Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 13.4.12.6. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 13.4.12.7. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.4.12.8. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 13.4.13. South Korea
      • 13.4.13.1. Overview
      • 13.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.4.13.3. South Korea Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 13.4.13.4. South Korea Market Size and Forecast, By Technology/Mode of Action, 2019 - 2032 (US$ Million)
      • 13.4.13.5. South Korea Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 13.4.13.6. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 13.4.13.7. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.4.13.8. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 13.4.14. Australia
      • 13.4.14.1. Overview
      • 13.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.4.14.3. Australia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 13.4.14.4. Australia Market Size and Forecast, By Technology/Mode of Action, 2019 - 2032 (US$ Million)
      • 13.4.14.5. Australia Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 13.4.14.6. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 13.4.14.7. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.4.14.8. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 13.4.15. Indonesia
      • 13.4.15.1. Overview
      • 13.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.4.15.3. Indonesia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 13.4.15.4. Indonesia Market Size and Forecast, By Technology/Mode of Action, 2019 - 2032 (US$ Million)
      • 13.4.15.5. Indonesia Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 13.4.15.6. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 13.4.15.7. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.4.15.8. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 13.4.16. Thailand
      • 13.4.16.1. Overview
      • 13.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.4.16.3. Thailand Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 13.4.16.4. Thailand Market Size and Forecast, By Technology/Mode of Action, 2019 - 2032 (US$ Million)
      • 13.4.16.5. Thailand Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 13.4.16.6. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 13.4.16.7. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.4.16.8. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 13.4.17. Philippines
      • 13.4.17.1. Overview
      • 13.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.4.17.3. Philippines Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 13.4.17.4. Philippines Market Size and Forecast, By Technology/Mode of Action, 2019 - 2032 (US$ Million)
      • 13.4.17.5. Philippines Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 13.4.17.6. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 13.4.17.7. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.4.17.8. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 13.4.18. Rest of APAC
      • 13.4.18.1. Overview
      • 13.4.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.4.18.3. Rest of APAC Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 13.4.18.4. Rest of APAC Market Size and Forecast, By Technology/Mode of Action, 2019 - 2032 (US$ Million)
      • 13.4.18.5. Rest of APAC Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 13.4.18.6. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 13.4.18.7. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.4.18.8. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 13.5. Latin America (LATAM)
    • 13.5.1. Overview
    • 13.5.2. Thoracic Outlet Syndrome Key Manufacturers in Latin America
    • 13.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 13.5.4. LATAM Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 13.5.5. LATAM Market Size and Forecast, By Technology/Mode of Action, 2019 - 2032 (US$ Million)
    • 13.5.6. LATAM Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
    • 13.5.7. LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 13.5.8. LATAM Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 13.5.9. LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 13.5.10. Brazil
      • 13.5.10.1. Overview
      • 13.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.5.10.3. Brazil Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 13.5.10.4. Brazil Market Size and Forecast, By Technology/Mode of Action, 2019 - 2032 (US$ Million)
      • 13.5.10.5. Brazil Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 13.5.10.6. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 13.5.10.7. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.5.10.8. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 13.5.11. Mexico
      • 13.5.11.1. Overview
      • 13.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.5.11.3. Mexico Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 13.5.11.4. Mexico Market Size and Forecast, By Technology/Mode of Action, 2019 - 2032 (US$ Million)
      • 13.5.11.5. Mexico Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 13.5.11.6. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 13.5.11.7. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.5.11.8. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 13.5.12. Argentina
      • 13.5.12.1. Overview
      • 13.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.5.12.3. Argentina Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 13.5.12.4. Argentina Market Size and Forecast, By Technology/Mode of Action, 2019 - 2032 (US$ Million)
      • 13.5.12.5. Argentina Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 13.5.12.6. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 13.5.12.7. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.5.12.8. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 13.5.13. Colombia
      • 13.5.13.1. Overview
      • 13.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.5.13.3. Colombia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 13.5.13.4. Colombia Market Size and Forecast, By Technology/Mode of Action, 2019 - 2032 (US$ Million)
      • 13.5.13.5. Colombia Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 13.5.13.6. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 13.5.13.7. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.5.13.8. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 13.5.14. Rest of LATAM
      • 13.5.14.1. Overview
      • 13.5.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.5.14.3. Rest of LATAM Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 13.5.14.4. Rest of LATAM Market Size and Forecast, By Technology/Mode of Action, 2019 - 2032 (US$ Million)
      • 13.5.14.5. Rest of LATAM Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 13.5.14.6. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 13.5.14.7. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.5.14.8. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 13.6. Middle East and Africa
    • 13.6.1. Overview
    • 13.6.2. Thoracic Outlet Syndrome Key Manufacturers in Middle East and Africa
    • 13.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 13.6.4. Middle East and Africa Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 13.6.5. Middle East and Africa Market Size and Forecast, By Technology/Mode of Action, 2019 - 2032 (US$ Million)
    • 13.6.6. Middle East and Africa Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
    • 13.6.7. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 13.6.8. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 13.6.9. Middle East and Africa Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 13.6.10. Saudi Arabia
      • 13.6.10.1. Overview
      • 13.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.6.10.3. Saudi Arabia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 13.6.10.4. Saudi Arabia Market Size and Forecast, By Technology/Mode of Action, 2019 - 2032 (US$ Million)
      • 13.6.10.5. Saudi Arabia Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 13.6.10.6. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 13.6.10.7. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.6.10.8. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 13.6.11. United Arab Emirates
      • 13.6.11.1. Overview
      • 13.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.6.11.3. United Arab Emirates Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 13.6.11.4. United Arab Emirates Market Size and Forecast, By Technology/Mode of Action, 2019 - 2032 (US$ Million)
      • 13.6.11.5. United Arab Emirates Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 13.6.11.6. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 13.6.11.7. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.6.11.8. United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 13.6.12. Israel
      • 13.6.12.1. Overview
      • 13.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.6.12.3. Israel Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 13.6.12.4. Israel Market Size and Forecast, By Technology/Mode of Action, 2019 - 2032 (US$ Million)
      • 13.6.12.5. Israel Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 13.6.12.6. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 13.6.12.7. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.6.12.8. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 13.6.13. Turkey
      • 13.6.13.1. Overview
      • 13.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.6.13.3. Turkey Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 13.6.13.4. Turkey Market Size and Forecast, By Technology/Mode of Action, 2019 - 2032 (US$ Million)
      • 13.6.13.5. Turkey Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 13.6.13.6. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 13.6.13.7. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.6.13.8. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 13.6.14. Algeria
      • 13.6.14.1. Overview
      • 13.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.6.14.3. Algeria Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 13.6.14.4. Algeria Market Size and Forecast, By Technology/Mode of Action, 2019 - 2032 (US$ Million)
      • 13.6.14.5. Algeria Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 13.6.14.6. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 13.6.14.7. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.6.14.8. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 13.6.15. Egypt
      • 13.6.15.1. Overview
      • 13.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.6.15.3. Egypt Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 13.6.15.4. Egypt Market Size and Forecast, By Technology/Mode of Action, 2019 - 2032 (US$ Million)
      • 13.6.15.5. Egypt Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 13.6.15.6. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 13.6.15.7. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.6.15.8. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 13.6.16. Rest of MEA
      • 13.6.16.1. Overview
      • 13.6.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.6.16.3. Rest of MEA Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 13.6.16.4. Rest of MEA Market Size and Forecast, By Technology/Mode of Action, 2019 - 2032 (US$ Million)
      • 13.6.16.5. Rest of MEA Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 13.6.16.6. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 13.6.16.7. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.6.16.8. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

14. Key Vendor Analysis- Thoracic Outlet Syndrome Industry

  • 14.1. Competitive Benchmarking
    • 14.1.1. Competitive Dashboard
    • 14.1.2. Competitive Positioning
  • 14.2. Company Profiles
    • 14.2.1. Stryker
    • 14.2.2. Globus Medical
    • 14.2.3. Becton Dickinson (BD)
    • 14.2.4. Smith and Nephew
    • 14.2.5. Hologi
    • 14.2.6. Zimmer Biomet
    • 14.2.7. Cook Medical
    • 14.2.8. Abbott
    • 14.2.9. B. Braun
    • 14.2.10. Teleflex
    • 14.2.11. Philips Healthcare
    • 14.2.12. Terumo Corporation
    • 14.2.13. Medtronic
    • 14.2.14. Cardinal Health
    • 14.2.15. Boston Scientific
    • 14.2.16. CONMED Corporation
    • 14.2.17. Johnson & Johnson (DePuy Synthes)
    • 14.2.18. Siemens Healthineers
    • 14.2.19. GE HealthCare
    • 14.2.20. Koninklijke Philips
    • 14.2.21. NuVasive
    • 14.2.22. Arthrex
    • 14.2.23. AngioDynamics
    • 14.2.24. Others

15. 360 Degree Analyst View

16. Appendix

  • 16.1. Research Methodology
  • 16.2. References
  • 16.3. Abbreviations
  • 16.4. Disclaimer
  • 16.5. Contact Us